Suggested Dosing
No typical dosing guidelines
Many different manufacturers; follow specific mfct suggestions
Next:
Suggested Uses
acute parotitis, upper respiratory tract infection, encephalitis, hepatitis, lung abscess, psoriasis, dysentery, acute gastroenteritis, prostate cancer, and HIV
Efficacy
There is insufficient evidence to support use for above indications
Previous
Next:
Adverse Effects
Frequency Not Defined
N/V
Hematuria
Previous
Next:
Warnings
Contraindications
Hypersensitivity
Previous
Next:
Pregnancy & Lactation
Pregnancy Category: N/A
Lactation: N/A
Pregnancy Categories
A: Generally acceptable. Controlled studies in pregnant women show no evidence of fetal risk.
B: May be acceptable. Either animal studies show no risk but human studies not available or animal studies showed minor risks and human studies done and showed no risk. C: Use with caution if benefits outweigh risks. Animal studies show risk and human studies not available or neither animal nor human studies done. D: Use in LIFE-THREATENING emergencies when no safer drug available. Positive evidence of human fetal risk. X: Do not use in pregnancy. Risks involved outweigh potential benefits. Safer alternatives exist. NA: Information not available.Previous
Next:
Pharmacology
Metabolism: N/A
Excretion: N/A
Mechanism of Action
Increased phagocytosis; anti-inflammatory
Previous
Medscape prescription drug monographs are based on FDA-approved labeling information, unless otherwise noted, combined with additional data derived from primary medical literature.
